Dr Rhys Morgan
Lecturer in Biomedical Science (Biochemistry)
Rhys' research seeks to investigate the role of a signal transduction pathway, Wnt/β-catenin signalling, in both normal blood development and haematological malignancy. Ultimately, Rhys is seeking to understand how this cell signalling pathway converts normal healthy blood cells into 'faulty' leukaemia cells, and develop novel therapeutic strategies for patients. His research is focused on one particularly aggressive blood cancer called acute myeloid leukaemia (AML).
Read more and contact Rhys >